JP Patent

JP2025531766A — 人工造影放射線画像の生成

Assigned to Bayer AG · Expires 2025-09-25 · 1y expired

What this patent protects

本開示は、人工造影放射線画像の生成の技術分野に関する。

USPTO Abstract

本開示は、人工造影放射線画像の生成の技術分野に関する。

Drugs covered by this patent

Elucirem (GADOPICLENOL) · Guerbet

Patent Metadata

Patent number: JP2025531766A
Jurisdiction: JP
Classification: —
Expires: 2025-09-25
Drug substance claim: No
Drug product claim: No
Assignee: Bayer AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.